Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections
Clinical trial NCT01964885 · TERMINATED
Trial details
- NCT number
- NCT01964885
- Sponsor
- InQpharm Group
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-04-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.